Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
In preclinical research, blocking NNMT raised NAD+ inside fat cells, increased their metabolic activity, and reduced fat-cell size notably without changes to diet
The Research Landscape Most of whats published on BPC-157 comes from preclinical and animal-model research rather than large human clinical trials
That said, it remains in the research stage
With FDA input pending, the companies are targeting a Phase 3 trial launch in the first half of 2026
Strategic Campaigning is Key A well-organised, targeted campaign is important
US$ 21.61
.jpeg)
US$ 21.34
US$ 21.28
US$ 25.84
US$ 28.78
